No definition available.
Other congenital malformations of peripheral vascular system
EFO MESH Endpoint Browser PheWeb
Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
490 |
4. Check minimum number of eventsNone |
490 |
5. Include endpointsNone |
490 |
6. Filter based on genotype QC (FinnGen only) |
490 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Aliae malformationes congenitae systematis vascularis peripherici
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of peripheral vascular system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3588 | 2038 | 1530 |
| Only index persons | 3103 | 1810 | 1293 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 27.46 | 30.77 | 22.92 |
| Only index persons | 31.03 | 32.77 | 28.60 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 490 | 322 | 168 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.07 |
| Median age at first event (years) | 44.06 | 40.95 | 50.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 425
- Matched controls
- 4250
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
+∞
170.6
152
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
+∞
154.9
139
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
100.0
92
*
D18.0
ICD-10 Finland
Haemangioma, any site
43.9
88.2
109
33
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
+∞
80.8
75
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
14.4
46.4
81
68
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
498.2
46.2
45
*
XX6KT
NOMESCO Finland
Other sclerotherapy
376.4
35.5
35
*
D18.1
ICD-10 Finland
Lymphangioma, any site
264.7
24.9
25
*
Z2221
NOMESCO Finland
Medical doctor
3.0
22.7
174
797
Q27.0
ICD-10 Finland
Congenital absence and hypoplasia of umbilical artery
+∞
21.0
20
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
20.4
184
918
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
19.3
201
1079
PG1HT
NOMESCO Finland
Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
+∞
18.9
18
*
Q82.50
ICD-10 Finland
Naevus flammeus
73.2
18.9
21
*
XX4BW
NOMESCO Finland
NA
55.0
18.1
21
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
18.1
131
559
EP1LT
NOMESCO Finland
Percutaneous sclerotherapy of vascular malformation of head and neck
+∞
16.8
16
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
14.2
16.7
28
21
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
+∞
15.7
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
14.7
77
260
R4110
NOMESCO Finland
Physiotherapy
2.5
14.5
135
658
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
+∞
13.6
13
*
JN5LT
NOMESCO Finland
Sclerotherapy with direct puncture body area
144.3
13.5
14
*
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
144.3
13.5
14
*
2280A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Haemangioma, any site
41.4
13.2
16
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
33.1
12.6
16
5
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
9.7
12.1
24
26
ZXC12
NOMESCO Finland
Pulse colorlaser
27.6
12.1
16
6
Q27.2
ICD-10 Finland
Other congenital malformations of renal artery
+∞
11.5
11
*
Q27.1
ICD-10 Finland
Congenital renal artery stenosis
+∞
11.5
11
*
PG1JT
NOMESCO Finland
Very extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
123.1
11.5
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
10.9
100
474
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
18.4
10.8
16
9
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
10.7
133
727
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.3
10.7
25
36
QX3KT
NOMESCO Finland
NA
+∞
10.5
10
*
ZXE00
NOMESCO Finland
One hour or less
2.0
10.4
188
1202
ZXA05
NOMESCO Finland
Left side
2.4
10.4
103
507
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
24.0
10.3
14
6
Z3231
NOMESCO Finland
Registered nurse
2.1
9.7
133
754
Z31.5
ICD-10 Finland
Genetic counselling
3.9
9.6
39
107
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
18.0
9.5
14
8
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
18.0
9.5
14
8
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
102.1
9.4
10
*
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
+∞
9.4
9
*
ZXA00
NOMESCO Finland
Right side
2.2
9.1
105
553
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
9.3
8.6
17
19
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
91.7
8.4
9
*
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
+∞
8.4
8
*
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
+∞
8.4
8
*
Q27.80
ICD-10 Finland
Congenital stricture, artery
+∞
8.4
8
*
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
34.0
8.1
10
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.3
8.0
23
45
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
7.9
70
323
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
7.8
30
79
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.4
7.5
26
62
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
81.4
7.4
8
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
81.4
7.4
8
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
7.3
7
*
PG1DG
NOMESCO Finland
Very extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
+∞
7.3
7
*
I15.0
ICD-10 Finland
Renovascular hypertension
30.5
7.2
9
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
12.3
7.1
12
10
WX402
NOMESCO Finland
General anaesthesia
2.1
7.0
83
436
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
7.0
67
323
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.6
6.7
18
33
H02AB06
ATC
prednisolone; systemic
1.7
6.7
176
1229
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.5
76
401
I87.8
ICD-10 Finland
Other specified disorders of veins
70.8
6.4
7
*
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
70.8
6.4
7
*
FM2CE
NOMESCO Finland
NA
8.3
6.4
13
16
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
6.4
148
993
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
6.1
6.4
16
27
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
6.3
27
79
M79.6
ICD-10 Finland
Pain in limb
1.8
6.3
135
883
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
6.3
6
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.1
6.2
8
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.8
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036489) Thrombin time
82
159
5.99
41.76
3.5
3.8
s
21.3
21.9
0.45
77
145
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
28
25
11.82
26.90
1.3
1.7
%
125.7
117.7
0.24
28
25
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
26
21
13.02
26.55
1.3
1.0
%
105.8
127.6
0.88
26
21
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
21
13.02
26.55
1.1
1.0
%
95.1
94.2
—
10
9
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
21
12.49
24.91
1.1
1.0
%
84.8
102.2
—
9
9
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
24
19
13.23
24.76
1.4
1.8
%
148.1
132.7
0.26
24
19
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
21
16
13.67
22.09
1.0
1.1
%
99.9
112.2
0.78
21
16
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
28
34
8.67
21.58
2.5
4.4
%
95.3
99.2
0.22
28
34
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
169
827
2.59
20.75
3.0
2.1
mg/l
1.1
1.0
0.20
127
633
(4306422)
34
55
6.57
20.46
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
65
5.55
17.27
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
66
5.46
16.99
1.2
1.2
u/ml
1.4
1.9
—
7
26
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
19
10.36
16.80
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
204
1175
2.26
16.66
2.7
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
205
1190
2.24
16.36
8.0
6.5
inr
1.1
1.2
0.51
61
387
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
69
5.22
16.18
1.2
1.2
u/ml
2.9
2.8
0.02
20
31
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
164
891
2.26
15.16
2.5
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
95
447
2.40
11.98
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
252
1779
1.86
10.20
4.3
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
96
504
2.13
9.16
3.5
2.3
g/l
2.5
2.4
0.88
89
467
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
89
465
2.12
8.57
3.8
2.4
%
21.9
23.7
0.54
80
401
(3021589) Normoblasts [#/volume] in Blood
253
1852
1.76
8.54
10.1
8.9
e9/l
0.0
0.0
0.49
204
1487
(40758558) Short blood count panel - Blood
160
1030
1.82
8.34
6.6
6.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
213
1492
1.76
8.33
2.2
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
249
1831
1.73
8.13
7.3
6.5
%
0.7
0.7
0.16
241
1724
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
233
1687
1.73
8.01
9.4
7.4
mmol/l
1.2
1.2
0.69
197
1456
(4035726)
60
274
2.36
7.99
1.4
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
275
2100
1.71
7.65
7.7
6.7
e9/l
0.2
0.2
0.17
244
1868
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
453
4044
2.59
7.59
15.3
11.4
mg/l
23.5
20.8
0.79
360
3054
(3006315) Basophils [#/volume] in Blood
267
2027
1.70
7.55
7.4
6.4
e9/l
0.0
0.0
0.99
235
1764
(3000991) Gas panel - Venous blood
64
308
2.24
7.54
15.1
10.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
266
2019
1.69
7.52
7.3
6.3
e9/l
0.5
0.6
0.37
235
1757
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1525
1.70
7.48
10.5
7.2
mmol/l
1.2
1.2
0.80
192
1409
(3019069) Monocytes/100 leukocytes in Blood
253
1905
1.68
7.29
7.4
6.7
%
8.7
8.3
1.91
244
1808
(3022948) Iron [Moles/volume] in Serum or Plasma
97
554
1.94
7.24
3.7
2.3
umol/l
12.6
14.0
1.18
91
508
(3002032) Base excess in Venous blood by calculation
67
335
2.16
7.18
4.6
7.0
mmol/l
1.4
1.5
0.08
54
263
(3013650) Neutrophils [#/volume] in Blood by Automated count
295
2318
1.69
7.18
9.2
9.2
e9/l
3.6
4.0
2.09
254
2016
(3019550) Sodium [Moles/volume] in Serum or Plasma
443
3941
2.29
7.04
17.3
12.4
mmol/l
139.8
139.6
1.59
434
3830
(3006504) Eosinophils/100 leukocytes in Blood
250
1894
1.65
6.90
7.3
6.4
%
3.0
2.8
0.61
242
1782
(40761511) CBC panel - Blood by Automated count
466
4254
2.95
6.77
13.4
10.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
255
1948
1.64
6.76
7.1
6.2
%
55.8
55.4
0.22
247
1850
(42870588) Differential panel, method unspecified - Blood
188
1330
1.67
6.73
7.6
6.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
270
2094
1.64
6.73
7.4
6.3
e9/l
1.9
2.0
1.46
242
1872
(3023103) Potassium [Moles/volume] in Serum or Plasma
443
3956
2.25
6.72
17.3
12.4
mmol/l
3.9
3.9
1.49
432
3830
(3042936) Bacteria identified in Isolate by Culture
85
478
1.94
6.61
2.2
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
65
3.50
6.49
3.9
11.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
34
4.52
6.27
4.8
17.6
%
8.9
11.8
1.76
15
34
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
93
3.01
6.26
1.3
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
255
1974
1.61
6.22
7.3
6.4
%
29.3
30.2
0.66
246
1874
(3024561) Albumin [Mass/volume] in Serum or Plasma
195
1419
1.62
6.11
6.6
5.0
g/l
36.9
36.8
0.14
183
1338
(3018095) Leukocytes [#/volume] in Urine
183
1312
1.63
6.09
3.7
3.7
e6/l
46.2
47.6
0.02
117
881
(3009542) Hematocrit [Volume Fraction] of Blood
435
3899
2.03
5.87
18.9
12.4
%
40.1
40.2
0.27
367
3156
(3007461) Platelets [#/volume] in Blood
483
4601
4.48
5.78
22.8
16.7
e9/l
253.6
258.4
0.87
473
4491
(3026361) Erythrocytes [#/volume] in Blood
483
4608
4.37
5.64
22.8
16.7
e12/l
4.5
4.5
1.20
472
4489
(3035941) MCH [Entitic mass]
483
4607
4.39
5.64
22.8
16.6
pg
30.0
30.0
0.44
478
4553
(3024731) MCV [Entitic volume]
483
4607
4.39
5.64
22.8
16.6
fl
90.1
89.9
0.31
478
4553
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
135
911
1.67
5.63
3.7
2.3
mg/l
3.3
2.9
0.55
121
789
(3000963) Hemoglobin [Mass/volume] in Blood
483
4612
4.31
5.48
23.5
16.8
g/l
133.9
135.7
1.95
478
4556
(3013826) Glucose [Moles/volume] in Serum or Plasma
265
2120
1.54
5.27
7.6
5.1
mmol/l
6.3
6.4
0.69
249
1945
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1305
1.56
5.03
3.7
3.2
u/l
27.2
31.7
1.76
171
1247
(3010813) Leukocytes [#/volume] in Blood
482
4610
3.79
4.99
22.9
16.7
e9/l
6.4
6.7
1.88
472
4485
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
52
272
2.02
4.95
14.3
11.9
mmol/l
25.5
24.6
1.09
52
272
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
333
2822
1.56
4.95
7.9
6.7
u/l
80.4
80.3
0.02
316
2661
(3018418) pH of Serum or Plasma
141
995
1.59
4.82
4.3
3.6
ph
7.4
7.4
0.06
22
175
(3030467) Casts [#/volume] in Urine by Automated count
138
972
1.58
4.74
3.0
3.1
e6/l
0.4
0.3
0.30
97
716
(36304419) Bacteria [Presence] in Urine
137
965
1.58
4.70
2.9
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
332
1.88
4.56
3.2
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
87
551
1.70
4.54
2.7
3.0
e6/l
3.0
2.7
0.09
41
292
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
361
3145
1.56
4.48
4.3
3.9
pmol/l
14.6
14.5
0.26
335
2901
(3023368) Bacteria identified in Blood by Culture
118
813
1.59
4.42
5.1
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
156
1149
1.52
4.34
3.9
3.1
mmol/l
2.4
2.4
0.00
134
1027
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
78
2.77
4.31
7.1
4.5
u/ml
0.3
0.3
0.71
12
44
(3002582) Erythrocytes [#/volume] in Urine
147
1072
1.53
4.27
3.1
3.2
e6/l
14.0
115.7
1.01
106
816
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
261
1.93
4.12
3.2
2.3
ml/min/173m2
70.5
74.1
0.23
15
103
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
228
1829
1.46
4.11
7.7
6.0
umol/l
12.2
11.4
0.31
212
1725
(3051651) Icteric interference index of Serum or Plasma
10
23
4.42
4.10
2.0
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
71
437
1.73
4.10
4.3
3.2
umol/l
5.4
8.1
1.36
60
365
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
10
8.11
4.07
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
165
1248
1.49
3.99
3.4
3.3
—
—
—
0
0
(3044889) 12 lead EKG panel
290
2448
1.45
3.92
3.6
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
573
1.63
3.89
2.6
2.9
e6/l
0.5
0.9
1.30
43
313
(4268621)
15
50
3.06
3.72
2.9
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
12
6.76
3.68
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
74
479
1.64
3.54
1.2
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
62
384
1.70
3.50
14.0
8.1
mmol/l
104.6
104.2
0.23
62
376
(3022217) INR in Platelet poor plasma by Coagulation assay
54
324
1.75
3.42
21.7
17.0
inr
1.6
1.2
—
6
52
(3026493) Urate [Moles/volume] in Serum or Plasma
117
849
1.50
3.40
2.9
3.0
umol/l
2922.1
5823.1
0.46
98
753
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
102
2.32
3.34
1.7
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
391
3550
1.50
3.24
13.5
9.8
ml/min/173m2
90.3
89.7
0.20
326
2795
(3034426) Prothrombin time (PT)
8
15
5.40
3.20
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
98
2.30
3.17
3.2
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
562
1.55
3.10
3.0
2.4
mmol/l
2.4
2.4
0.56
67
486
(3051611) Lipemic interference index of Serum or Plasma
10
29
3.50
3.06
2.2
3.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
71
472
1.59
3.06
9.0
7.3
mmol/l
1.2
1.1
0.48
66
446
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
46
274
1.75
3.00
2.8
3.3
pmol/l
4.5
4.6
0.43
41
241
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
20
88
2.33
2.97
2.1
2.6
ug/l
598.3
294.1
0.63
20
81
(4062490)
13
46
2.88
2.94
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
100
726
1.47
2.88
2.4
2.5
e6/l
7.6
6.9
0.14
89
649
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
879
1.43
2.81
3.0
3.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
266
1.72
2.74
8.0
6.5
mmol/l
1.1
1.0
0.10
33
194
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
92
2.22
2.71
1.3
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
24
3.80
2.68
1.7
1.8
umol/l
21.4
32.5
—
9
24
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
402
3714
1.46
2.64
5.1
4.6
mu/l
1.8
2.2
0.59
378
3477
(3007853) Bacteria identified in Skin by Aerobe culture
66
448
1.55
2.61
2.1
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
312
2767
1.35
2.60
3.5
3.1
u/l
40.1
40.2
0.00
297
2635
(3023520) Reticulocytes [#/volume] in Blood
44
271
1.69
2.57
3.7
3.4
e9/l
61.0
70.5
1.56
28
195
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
21
3.85
2.47
1.9
1.4
mmol/l
5.4
6.5
—
8
21
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
51
2.59
2.46
1.2
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
64
2.39
2.41
3.3
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
80
577
1.46
2.38
1.5
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
228
1949
1.32
2.37
4.2
2.9
ug/l
89.5
83.7
0.19
210
1819
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
86
2.13
2.25
2.1
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
213
0.41
2.24
1.6
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
79
576
1.44
2.22
4.6
3.0
ng/l
148.7
218.9
0.30
54
367
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
36
2.81
2.21
1.1
1.3
promille
2.0
1.3
—
5
27
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
24
3.37
2.19
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
154
1257
1.33
2.18
2.1
1.9
pmol/l
91.2
96.9
0.89
82
638
(3003338) MCHC [Mass/volume]
395
3673
1.39
2.18
20.0
14.6
g/l
331.4
333.3
3.38
389
3649
(3026782) Osmolality of Urine
92
694
1.40
2.15
2.5
2.6
mosm/kgh2o
586.7
553.2
0.64
80
592
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
446
4245
1.56
2.14
10.8
8.9
u/l
24.6
25.9
1.32
431
4107
(3013707) Erythrocyte sedimentation rate by Westergren method
318
2871
1.31
2.11
4.3
3.8
mm/h
9.5
9.9
0.26
294
2649
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
31
2.94
2.08
2.3
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
57
2.32
1.99
2.3
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
152
1254
1.31
1.97
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
157
1.76
1.97
2.3
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
71
521
1.42
1.94
5.3
4.6
mmol/l
0.8
0.8
0.07
64
490
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
45
2.48
1.94
1.1
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
144
1182
1.31
1.94
2.9
3.1
ng/l
29.2
33.7
0.18
81
668
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
158
1.75
1.93
1.3
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
85
2.04
1.92
1.1
1.1
u/ml
7.7
1.6
—
6
41
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
85
2.04
1.92
4.5
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
51
353
1.50
1.88
2.8
2.5
u/l
24.7
29.7
2.09
45
295
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
86
2.01
1.87
1.2
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
46
2.42
1.86
1.5
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
12
4.20
1.82
1.6
2.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
116
1.85
1.81
1.1
1.6
u/ml
229.8
216.3
0.12
14
61
(3045142) Bone marrow Pathology biopsy report
9
35
2.60
1.81
1.1
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
177
1.68
1.80
1.5
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
295
2667
1.27
1.79
4.0
3.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
36
2.53
1.74
2.6
2.3
pg
31.2
33.4
—
9
36
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
359
1.47
1.74
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
48
2.32
1.71
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
82
1.98
1.71
2.2
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
226
0.47
1.69
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.68
2.7
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
10
42
2.41
1.68
1.1
1.3
—
90.0
—
0
6
(3022313) Gas panel - Capillary blood
34
221
1.58
1.67
9.7
6.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
62
2.13
1.67
2.3
1.7
—
—
—
0
0
(3036603) Volume of Urine
7
25
2.83
1.65
1.4
1.8
—
1998.3
—
0
6
(40767503) Oxygen content in Capillary blood by calculation
12
56
2.17
1.62
1.6
2.7
%
18.1
15.6
—
7
29
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
14
3.60
1.62
4.4
3.6
ug/l
64.2
160.8
—
5
14
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
121
1.77
1.61
1.1
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
33
2.45
1.54
1.5
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
33
2.45
1.54
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
21
2.88
1.51
1.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
58
2.10
1.50
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
72
1.97
1.50
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
72
1.97
1.50
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
58
432
1.39
1.48
1.6
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
131
1097
1.27
1.48
2.3
2.5
u/l
52.5
54.1
0.30
113
1024
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
968
1.27
1.46
1.8
1.7
mmol/l
1.3
1.4
0.82
101
842
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
59
2.06
1.44
2.2
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
16
3.15
1.44
2.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
39
2.33
1.43
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
126
1.70
1.42
1.4
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
46
2.20
1.40
2.2
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
96
1.80
1.40
1.1
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
13
67
1.97
1.39
4.6
2.4
kpa
5.3
4.9
1.08
13
67
(3027315) Oxygen [Partial pressure] in Blood
13
67
1.97
1.39
4.6
2.4
kpa
8.6
9.1
0.48
13
67
(3003396) Base excess in Arterial blood by calculation
44
316
1.43
1.39
21.3
9.8
mmol/l
1.4
0.9
0.26
37
259
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
127
1.68
1.39
1.4
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
41
2.22
1.37
1.1
1.3
nmol/l
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
41
2.22
1.37
1.8
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
120
1.70
1.36
2.8
1.8
iu/l
2.0
5.6
—
8
41
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
128
1.67
1.35
1.4
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
47
344
1.41
1.34
2.1
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
209
1.52
1.34
1.5
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
115
961
1.26
1.32
2.4
2.1
u/l
183.3
255.1
0.47
110
910
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
390
1.37
1.30
2.4
2.0
nmol/l
379.2
380.8
0.02
45
364
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
18
2.80
1.29
1.0
1.2
miu/ml
1543.2
1642.1
—
5
18
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
1105
1.24
1.28
2.1
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
48
357
1.38
1.26
1.2
1.2
iu/ml
87.9
173.6
1.12
12
143
(4198724)
6
25
2.42
1.24
1.2
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
58
447
1.34
1.23
1.7
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
49
2.06
1.22
2.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
78
1.82
1.22
3.4
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
198
0.55
1.18
1.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
406
1.34
1.17
1.2
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
63
496
1.31
1.16
1.9
1.6
nmol/l
1165.0
1182.7
0.05
46
384
(3045414) Leukocytes [Presence] in Urine
8
154
0.51
1.16
2.0
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
225
1.45
1.15
1.7
2.3
ug/l
2.5
5.9
2.95
25
201
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
(3000492) Spirometry study
52
399
1.34
1.14
1.7
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
345
3248
1.21
1.14
3.4
3.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
960
1.23
1.12
4.7
4.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
112
1.63
1.10
1.2
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
21
2.39
1.09
1.6
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
2.2
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
13
74
1.78
1.07
7.9
4.3
umol/l
39.3
38.5
0.06
13
67
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
1.0
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
33
2.14
1.06
1.4
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
1.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
1.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
67
1.81
1.05
1.1
1.1
—
—
—
0
0
(44790047)
9
46
1.97
1.04
2.3
1.8
—
—
—
0
0
(44790049)
9
46
1.97
1.04
2.3
1.8
—
—
—
0
0
(44790048)
9
46
1.97
1.04
2.3
1.8
—
—
—
0
0
(44806118)
9
46
1.97
1.04
2.3
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
46
1.97
1.04
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
587
1.27
1.03
1.5
1.4
titre
532.3
588.5
0.09
13
122
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
396
3794
1.23
1.02
4.1
4.2
mmol/l
2.9
2.8
0.42
365
3560
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
48
1.89
1.01
1.2
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
158
0.56
1.00
2.1
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
337
1.34
0.99
2.2
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
35
261
1.37
0.94
19.7
10.5
g/l
121.1
121.3
0.01
35
251
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
37
1.90
0.94
1.3
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
37
1.90
0.94
1.3
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
37
1.90
0.94
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
392
3761
1.21
0.94
3.8
3.8
mmol/l
4.7
4.7
0.07
363
3555
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
379
3625
1.20
0.94
3.6
3.7
mmol/l
5.7
5.7
0.31
351
3362
(21494434) Karyotype in Bone marrow
6
27
2.24
0.93
1.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
390
3741
1.21
0.93
3.8
3.8
mmol/l
1.5
1.5
0.11
364
3518
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
126
1.53
0.92
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
176
1586
1.17
0.91
3.1
2.4
nmol/l
74.0
73.1
0.16
164
1450
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
56
1.80
0.88
2.3
2.8
u/ml
2.7
11.4
—
10
50
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
371
1.30
0.88
6.8
5.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
498
1.26
0.88
2.1
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
378
3623
1.19
0.87
3.3
3.5
mmol/l
1.3
1.3
0.08
351
3405
(40768443) Skin Pathology biopsy report
21
145
1.47
0.86
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
31
1.95
0.84
2.3
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
45
1.79
0.84
1.3
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
885
1.19
0.83
1.6
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
97
1.56
0.82
2.4
2.2
mg/l
10.8
10.2
0.10
15
89
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
164
1.42
0.81
1.5
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
69
578
1.23
0.80
1.7
1.8
%
1.3
1.4
0.60
60
526
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
165
1.41
0.79
1.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
99
1.53
0.76
1.3
1.3
—
—
—
0
0
(4024509)
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
59
1.71
0.76
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
24
2.09
0.74
2.4
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
85
733
1.19
0.74
1.7
1.4
nmol/l
22.7
21.3
0.34
77
636
(4010399)
34
264
1.31
0.74
1.5
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.74
1.3
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.74
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
38
1.85
0.74
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
291
1.29
0.73
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
81
697
1.19
0.73
1.2
1.3
iu/ml
16.1
27.9
1.33
21
205
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
56
1.62
0.72
1.2
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
10
60
1.68
0.72
1.8
1.5
mmol/l
8.3
7.0
—
10
41
(3023410) Appearance of Cerebral spinal fluid
9
57
1.59
0.71
1.3
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
96
1090
0.85
0.71
3.1
2.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
2.1
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
206
1910
1.14
0.69
4.4
4.6
estimate
0.0
0.0
0.50
33
384
(3005033) Fetal Nuchal fold Thickness US
22
161
1.38
0.69
1.4
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
59
1.54
0.68
1.6
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
59
1.54
0.68
1.6
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
42
1.68
0.68
1.3
1.2
mu/l
98.0
261.4
—
7
36
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
214
1.33
0.68
2.1
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
22
162
1.37
0.67
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
278
1.28
0.66
1.4
1.5
iu/l
22.8
21.5
0.09
27
224
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
137
1.40
0.65
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
425
1.22
0.64
2.1
2.7
ug/l
0.6
0.7
1.13
30
257
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
84
734
1.17
0.64
3.7
4.2
ug/l
1.6
2.3
0.93
72
671
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
96
1.47
0.62
2.0
1.4
ug/g
267.6
303.6
—
9
54
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
851
1.16
0.62
2.2
2.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
139
0.64
0.61
1.2
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
72
624
1.18
0.61
3.7
2.6
ug/g
191.7
93.1
0.86
60
481
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
53
1.52
0.58
1.3
2.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
23
0.00
0.58
0.0
2.2
—
562.2
—
0
13
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
23
0.00
0.58
0.0
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
31
247
1.27
0.58
3.5
3.6
mmol/l
1.2
1.2
0.30
26
215
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
184
0.70
0.58
1.2
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
347
3345
1.13
0.57
4.5
4.8
mmol/mol
37.4
38.5
1.75
327
3164
(1001926) Buprenorphine [Presence] in Urine by Screen method
30
239
1.27
0.56
2.4
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
415
0.81
0.55
1.1
1.2
—
—
—
0
0
(44813793)
6
37
1.63
0.55
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
82
1.48
0.55
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
60
1.51
0.54
2.4
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
259
1.25
0.54
5.2
4.8
%
13.2
0.1
—
5
71
(3035637) Corticotropin [Mass/volume] in Plasma
9
62
1.46
0.53
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
127
1.35
0.50
1.5
1.8
—
234.3
—
0
7
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
137
1482
0.90
0.50
3.4
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
262
1.24
0.50
3.1
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
33
272
1.23
0.48
5.0
4.7
%
0.2
0.1
—
5
83
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
93
1.41
0.48
2.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
46
1.53
0.48
1.9
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
205
1935
1.10
0.47
3.2
3.3
estimate
0.0
0.0
0.50
31
369
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
218
1.25
0.47
1.4
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
85
1.42
0.47
1.3
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
35
292
1.21
0.46
4.9
4.5
%
1.5
0.9
—
6
95
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
156
1.29
0.45
35.5
13.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
86
1.41
0.45
1.1
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
202
1.25
0.44
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
202
1.25
0.44
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
2.3
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
78
1.42
0.43
1.3
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
203
1.24
0.43
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
203
1.24
0.43
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
93
0.64
0.42
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
93
0.64
0.42
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
167
1.27
0.42
8.5
7.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.4
1.2
nmol/l
49.9
43.8
—
5
23
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
74
665
1.13
0.42
1.4
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
33
1.52
0.41
2.0
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
278
1.20
0.41
1.6
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
17
0.00
0.40
0.0
3.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
8.3
—
0
17
(3016750) Collection duration of Urine
0
18
0.00
0.40
0.0
2.1
—
504.1
—
0
11
(3000764) Benzodiazepines [Presence] in Urine
35
298
1.19
0.39
2.3
1.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
mg/l
354.0
198.1
—
5
30
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
261
1.20
0.39
4.5
4.5
%
0.8
0.4
—
5
64
(3003327) Ova and parasites identified in Stool by Light microscopy
20
160
1.26
0.39
1.4
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
200
1901
1.09
0.39
3.2
3.3
estimate
0.0
0.0
0.00
30
379
(4211845)
0
19
0.00
0.39
0.0
3.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
6.8
—
49.0
—
0
5
(3027008) Opiates [Presence] in Urine
35
299
1.18
0.38
2.2
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
299
1.18
0.38
2.3
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
36
1.39
0.38
4.0
2.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
75
680
1.12
0.37
2.0
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
37
1.35
0.37
1.6
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
35
301
1.18
0.36
2.3
1.8
—
—
—
0
0
(4034850)
9
122
0.73
0.35
12.4
8.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
34
293
1.17
0.34
1.1
1.2
—
131.8
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
44
1.37
0.34
4.8
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
773
1.10
0.33
2.1
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
229
1.19
0.33
1.3
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
198
0.80
0.32
1.8
1.8
mg/l
3.1
3.7
0.14
11
141
(3019225) pH of Specimen
32
277
1.17
0.31
4.1
4.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
22
261
0.84
0.31
1.6
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
53
1.33
0.31
1.9
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
7
100
0.70
0.31
8.7
9.5
%
0.7
0.9
—
7
92
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
79
728
1.10
0.31
4.1
3.3
ng/l
1396.0
917.1
0.73
62
602
(3025130) Human papilloma virus identified in Specimen
10
75
1.34
0.30
1.4
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
72
661
1.10
0.30
1.7
1.6
pmol/l
451.0
26132839.8
0.80
59
574
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
36
316
1.15
0.30
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
115
1081
1.08
0.29
3.8
3.2
mmol/l
8.3
8.1
0.09
100
930
(3016879) Cocaine [Presence] in Urine
32
279
1.16
0.29
2.3
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
108
1149
0.92
0.29
1.4
1.4
u/ml
1.2
2.1
0.63
31
294
(3025941) Bacteria identified in Stool by Culture
26
223
1.18
0.29
1.5
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
112
1.26
0.28
1.7
1.3
—
54.0
—
0
10
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
158
1.21
0.28
1.7
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
76
1.32
0.28
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.5
2.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
263
1.15
0.26
1.7
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
77
1.30
0.26
1.2
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
169
1.19
0.26
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
132
1.22
0.26
3.4
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
127
0.78
0.25
1.9
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
207
1.17
0.25
3.3
2.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
201
0.84
0.24
1.1
1.4
miu/ml
309.0
258.5
—
8
106
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
38
1.32
0.23
1.4
1.3
mg/l
43.0
28.8
—
5
27
(3047181) Lactate [Moles/volume] in Blood
7
92
0.76
0.22
8.6
10.5
mmol/l
1.3
1.2
—
7
80
(3024263) Appearance of Synovial fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.3
—
402.0
—
0
6
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
11
0.00
0.21
0.0
2.5
—
1.2
—
0
11
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
489
0.91
0.20
2.0
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
13
108
1.21
0.20
2.4
3.3
u/ml
82.8
1412.1
0.52
13
91
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
203
1.14
0.19
1.3
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
59
1.19
0.18
3.6
3.0
u/ml
17.7
30.3
—
7
59
(4094501)
10
82
1.22
0.17
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
68
0.73
0.17
1.8
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
139
1.16
0.16
1.9
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
256
0.89
0.16
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
595
1.07
0.16
2.7
3.9
%
21.9
21.5
0.07
25
260
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
83
1.21
0.15
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
18
203
0.88
0.15
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
379
0.92
0.15
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
813
1.06
0.15
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
93
1.19
0.14
1.4
2.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
98
0.81
0.14
7.8
9.6
%
1.4
1.6
—
8
89
(1761868) Lipid panel - Serum or Plasma
145
1489
0.96
0.12
2.6
2.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
85
1.18
0.12
2.5
3.5
mmol/l
22.9
24.3
—
10
74
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
280
1.08
0.10
2.3
4.1
ug/l
3.1
25.2
0.81
20
227
(3049717) Cytology report of Urine Cyto stain
11
96
1.15
0.10
2.0
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
44
1.14
0.10
4.0
3.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
390
1.06
0.09
4.4
3.8
%
33.1
31.6
0.34
30
274
(3007164) IgA [Mass/volume] in Serum or Plasma
108
1054
1.03
0.08
1.6
1.4
g/l
2.0
2.1
0.40
70
637
(3032773) Endomysium IgG Ab [Titer] in Serum
5
62
0.80
0.08
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
106
1035
1.03
0.08
2.7
2.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
98
1.13
0.07
2.4
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
118
1156
1.03
0.07
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
336
0.95
0.07
3.9
3.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
10
89
1.13
0.07
11.2
3.6
mmol/l
3.6
3.9
—
10
81
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
66
679
0.97
0.06
1.3
1.3
u/ml
18.1
8.2
0.43
25
266
(3029937) Albumin [Presence] in Urine by Test strip
100
1020
0.98
0.06
3.9
3.5
estimate
0.0
0.0
0.80
33
377
(3020682) Albumin/Creatinine [Ratio] in Urine
88
899
0.97
0.06
4.9
4.0
mg/mmol
5.2
10.5
1.47
60
589
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
120
1.09
0.05
1.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
120
1.09
0.05
1.0
1.1
u/ml
2.2
6.9
—
8
74
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
130
0.92
0.04
2.0
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
53
516
1.03
0.04
2.6
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
288
1.04
0.04
2.2
2.3
u/l
230.4
3785.7
—
10
118
(3019150) Specific gravity of Urine by Refractometry
86
876
0.98
0.04
3.8
3.3
kg/l
1.0
1.0
—
7
117
(3013512) EKG study
89
877
1.02
0.03
3.2
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
142
1.06
0.02
1.2
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
178
0.95
0.02
1.2
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
103
1.07
0.02
2.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
413
1.02
0.01
2.5
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
134
1.05
0.00
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
27
265
1.02
0.00
1.5
2.3
e9/l
3.7
4.1
0.73
22
232
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
117
1.03
0.00
1.0
1.1
u/ml
0.1
1.3
—
7
63
(3020891) Body temperature
12
117
1.03
0.00
12.1
4.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
53
527
1.01
0.00
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
86
865
0.99
0.00
4.1
3.3
mg/l
37.7
372.4
1.52
60
576
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.0
—
75.0
—
0
6
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
2.7
—
0
6
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
2.2
—
0
6
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
6.1
—
0
6
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
1.4
—
0
6
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
2.2
—
0
6
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
54
0.93
0.00
2.0
5.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
2.9
—
0
6
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
1.2
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
59.2
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.8
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
17
170
1.00
0.00
13.7
9.5
mmol/l
27.0
24.6
0.81
17
157
(3004616) Nuclear Ab [Presence] in Serum
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
52
0.96
0.00
2.6
3.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
79
0.88
0.00
5.0
3.6
e9/l
4.3
4.1
—
7
79
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
3.7
—
0
7
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.0
—
0
5
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
79
0.88
0.00
6.6
3.9
%
57.4
55.7
—
7
79
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
2.0
—
0
8
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM | 1.126 [0.85, 1.5] | 0.416 |
| Birth year | 0.994 [0.99, 1.0] | 0.189 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 1690 females with Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM | 1.198 [0.87, 1.65] | 0.266 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 1287 males with Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.135% | 0.224% |
| 5 | 0.647% | 1.384% |
| 10 | 1.645% | 3.654% |
| 15 | 3.268% | 6.451% |
| 20 | 5.809% | 10.974% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM – Other congenital malformations of peripheral vascular system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data